Evaluation of risk minimisation activities for cyproterone acetate 2 mg/ethinylestradiol 35 mu g:Kimberly Davis,Alex Asiimwe,Laurie Zografos,David J. McSorley,Elizabeth AndrewsPHARMACOEPIDEMIOLOGY AND DRUG SAFETY(2016)引用 9|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要